ciprofloxacin has been researched along with Adnexitis in 23 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Adnexitis: Inflammation of the uterine appendages (ADNEXA UTERI) including infection of the FALLOPIAN TUBES (SALPINGITIS), the ovaries (OOPHORITIS), or the supporting ligaments (PARAMETRITIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "This multicentre, double-blind study was undertaken to demonstrate non-inferiority of once-daily oral moxifloxacin compared with combination therapy in the management of acute, uncomplicated pelvic inflammatory disease (PID)." | 9.14 | A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease. ( Heystek, M; Ross, JD, 2009) |
| "One hundred and sixty five women with diagnosis of pelvic inflammatory disease were randomized into three equal groups getting ciprofloxacin (500 mg) and tinidazole (600 mg) combination twice daily for 7 days (Group 1), a kit containing fluconazole (150 mg), azithromycin (1 gm) and secnidazole (2 mg) as one time dose (Group 2) and Doxycycline 100mg twice daily and metronidazole 200 mg thrice daily for seven days (Group 3)." | 9.10 | Ciprofloxacin-tinidazole combination, fluconazole- azithromicin-secnidazole-kit and doxycycline- metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial. ( Arora, R; Batra, S; Malhotra, M; Sharma, JB; Sharma, S, 2003) |
| "This multicenter, prospective, double-blind study compared the safety and efficacy of clindamycin and ciprofloxacin versus ceftriaxone and doxycycline in the treatment of outpatients with mild to moderate pelvic inflammatory disease (PID) diagnosed by laparoscopy." | 9.08 | Oral clindamycin and ciprofloxacin versus intramuscular ceftriaxone and oral doxycycline in the treatment of mild-to-moderate pelvic inflammatory disease in outpatients. ( Arredondo, JL; Diaz, V; Gaitan, H; Maradiegue, E; Oyarzún, E; Paz, R; Reynal, JL; Stamm, W; Zambrano, D, 1997) |
| "A prospective, randomized, controlled, non-blind clinical trial was conducted to compare the efficacy of monotherapy with ciprofloxacin with that of a combination of clindamycin plus gentamicin in the treatment of patients with acute pelvic inflammatory disease." | 9.06 | Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin. ( Crombleholme, WR; Luft, J; Ohm-Smith, M; Schachter, J; Sweet, RL; Whidden, R, 1989) |
| "Ciprofloxacin treatment was successful in all nine patients with chlamydial or gonococcal PID and in six of seven with nonchlamydial nongonococcal PID." | 6.66 | A comparison of ciprofloxacin with doxycycline plus metronidazole in the treatment of acute pelvic inflammatory disease. ( Aine, R; Grönroos, P; Heinonen, PK; Miettinen, A; Punnonen, R; Teisala, K, 1989) |
| "The clinical diagnosis of pelvic inflammatory disease (PID) is inexact." | 5.35 | Pelvic inflammatory disease with Tc-99m ciprofloxacin imaging. ( Choe, W; Hwang, SO; Im, MW; Lee, WY; Song, ES, 2008) |
| "Ciprofloxacin was less effective than combination treatment against Gardnerella vaginalis." | 5.28 | The effect of ciprofloxacin and doxycycline plus metronidazole on lower genital tract flora in patients with proven pelvic inflammatory disease. ( Heinonen, PK; Laine, S; Miettinen, A; Teisala, K, 1991) |
| " The dosage was 2 X 500 mg ciprofloxacin orally every 12 h for 7." | 5.27 | Is pelvic inflammatory disease an indication for treatment with ciprofloxacin? ( Chyský, V; Hägele, D, 1988) |
| "This multicentre, double-blind study was undertaken to demonstrate non-inferiority of once-daily oral moxifloxacin compared with combination therapy in the management of acute, uncomplicated pelvic inflammatory disease (PID)." | 5.14 | A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease. ( Heystek, M; Ross, JD, 2009) |
| "One hundred and sixty five women with diagnosis of pelvic inflammatory disease were randomized into three equal groups getting ciprofloxacin (500 mg) and tinidazole (600 mg) combination twice daily for 7 days (Group 1), a kit containing fluconazole (150 mg), azithromycin (1 gm) and secnidazole (2 mg) as one time dose (Group 2) and Doxycycline 100mg twice daily and metronidazole 200 mg thrice daily for seven days (Group 3)." | 5.10 | Ciprofloxacin-tinidazole combination, fluconazole- azithromicin-secnidazole-kit and doxycycline- metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial. ( Arora, R; Batra, S; Malhotra, M; Sharma, JB; Sharma, S, 2003) |
| "This multicenter, prospective, double-blind study compared the safety and efficacy of clindamycin and ciprofloxacin versus ceftriaxone and doxycycline in the treatment of outpatients with mild to moderate pelvic inflammatory disease (PID) diagnosed by laparoscopy." | 5.08 | Oral clindamycin and ciprofloxacin versus intramuscular ceftriaxone and oral doxycycline in the treatment of mild-to-moderate pelvic inflammatory disease in outpatients. ( Arredondo, JL; Diaz, V; Gaitan, H; Maradiegue, E; Oyarzún, E; Paz, R; Reynal, JL; Stamm, W; Zambrano, D, 1997) |
| "A prospective, randomized, controlled, non-blind clinical trial was conducted to compare the efficacy of monotherapy with ciprofloxacin with that of a combination of clindamycin plus gentamicin in the treatment of patients with acute pelvic inflammatory disease." | 5.06 | Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin. ( Crombleholme, WR; Luft, J; Ohm-Smith, M; Schachter, J; Sweet, RL; Whidden, R, 1989) |
| "Ciprofloxacin treatment was successful in all nine patients with chlamydial or gonococcal PID and in six of seven with nonchlamydial nongonococcal PID." | 2.66 | A comparison of ciprofloxacin with doxycycline plus metronidazole in the treatment of acute pelvic inflammatory disease. ( Aine, R; Grönroos, P; Heinonen, PK; Miettinen, A; Punnonen, R; Teisala, K, 1989) |
| "Treatment of pelvic inflammatory disease (PID) should provide high rates of clinical and microbiological cure for a range of pathogens and should ultimately prevent reproductive morbidity." | 2.44 | Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials. ( Haggerty, CL; Ness, RB, 2007) |
| "We describe a woman with suspected pelvic inflammatory disease eventually confirmed as Salmonella O C2 infection." | 1.35 | Salmonella: the pelvic masquerader. ( Valayatham, V, 2009) |
| "The clinical diagnosis of pelvic inflammatory disease (PID) is inexact." | 1.35 | Pelvic inflammatory disease with Tc-99m ciprofloxacin imaging. ( Choe, W; Hwang, SO; Im, MW; Lee, WY; Song, ES, 2008) |
| "Ciprofloxacin was less effective than combination treatment against Gardnerella vaginalis." | 1.28 | The effect of ciprofloxacin and doxycycline plus metronidazole on lower genital tract flora in patients with proven pelvic inflammatory disease. ( Heinonen, PK; Laine, S; Miettinen, A; Teisala, K, 1991) |
| " The dosage was 2 X 500 mg ciprofloxacin orally every 12 h for 7." | 1.27 | Is pelvic inflammatory disease an indication for treatment with ciprofloxacin? ( Chyský, V; Hägele, D, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (34.78) | 18.7374 |
| 1990's | 7 (30.43) | 18.2507 |
| 2000's | 8 (34.78) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Valayatham, V | 1 |
| Im, MW | 2 |
| Choe, W | 2 |
| Hwang, SO | 1 |
| Song, ES | 1 |
| Lee, WY | 1 |
| Heystek, M | 1 |
| Ross, JD | 1 |
| Altunyurt, S | 1 |
| Demir, N | 1 |
| Posaci, C | 1 |
| Malhotra, M | 1 |
| Sharma, JB | 1 |
| Batra, S | 1 |
| Arora, R | 1 |
| Sharma, S | 1 |
| Das, S | 1 |
| Kirwan, J | 1 |
| Drakeley, AJ | 1 |
| Kingsland, CR | 1 |
| Loendersloot, E | 1 |
| Branolte, JH | 1 |
| De Wilde, R | 1 |
| Haggerty, CL | 1 |
| Ness, RB | 1 |
| Doganov, N | 1 |
| Iarŭkov, A | 1 |
| Karag'ozov, I | 1 |
| Bozhilov, D | 1 |
| Diavolov, V | 1 |
| Fischbach, F | 1 |
| Deckardt, R | 1 |
| Graeff, H | 1 |
| Arredondo, JL | 1 |
| Diaz, V | 1 |
| Gaitan, H | 1 |
| Maradiegue, E | 1 |
| Oyarzún, E | 1 |
| Paz, R | 1 |
| Reynal, JL | 1 |
| Stamm, W | 1 |
| Zambrano, D | 1 |
| Chung, JK | 1 |
| Jeong, JM | 1 |
| Monif, GR | 1 |
| Osborne, NG | 1 |
| Thadepalli, H | 1 |
| Mathai, D | 1 |
| Scotti, R | 1 |
| Bansal, MB | 1 |
| Savage, E | 1 |
| Miettinen, A | 3 |
| Laine, S | 1 |
| Teisala, K | 3 |
| Heinonen, PK | 3 |
| Crombleholme, WR | 1 |
| Schachter, J | 1 |
| Ohm-Smith, M | 1 |
| Luft, J | 1 |
| Whidden, R | 1 |
| Sweet, RL | 1 |
| Aine, R | 2 |
| Punnonen, R | 1 |
| Grönroos, P | 1 |
| Ranta, T | 2 |
| Kostiala, AA | 2 |
| Hägele, D | 1 |
| Chyský, V | 1 |
1 review available for ciprofloxacin and Adnexitis
| Article | Year |
|---|---|
Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Clindamycin; Dose-Response Relati | 2007 |
9 trials available for ciprofloxacin and Adnexitis
| Article | Year |
|---|---|
A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease.
Topics: Acute Disease; Adult; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Double-Blind Method; Doxy | 2009 |
A randomized controlled trial of coil removal prior to treatment of pelvic inflammatory disease.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Device Removal; Doxycycline; Female; Hu | 2003 |
Ciprofloxacin-tinidazole combination, fluconazole- azithromicin-secnidazole-kit and doxycycline- metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial.
Topics: Adolescent; Adult; Azithromycin; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Female; Fluc | 2003 |
[The clinical study of the preparation ciprofloxacin in inflammatory gynecological diseases].
Topics: Acute Disease; Adult; Analysis of Variance; Chronic Disease; Ciprofloxacin; Endometritis; Female; Hu | 1993 |
[Ciprofloxacin/metronidazole vs. cefoxitin/doxycycline: comparison of two therapy schedules for treatment of acute pelvic infection].
Topics: Adult; Bacterial Infections; Bacteriological Techniques; Cefoxitin; Ciprofloxacin; Dose-Response Rel | 1994 |
Oral clindamycin and ciprofloxacin versus intramuscular ceftriaxone and oral doxycycline in the treatment of mild-to-moderate pelvic inflammatory disease in outpatients.
Topics: Administration, Oral; Adult; Ceftriaxone; Ciprofloxacin; Clindamycin; Double-Blind Method; Doxycycli | 1997 |
Ciprofloxacin monotherapy for acute pelvic infections: a comparison with clindamycin plus gentamicin.
Topics: Acute Disease; Adolescent; Adult; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Female; Gen | 1991 |
Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin.
Topics: Acute Disease; Adult; Bacteria; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Female; Genta | 1989 |
A comparison of ciprofloxacin with doxycycline plus metronidazole in the treatment of acute pelvic inflammatory disease.
Topics: Acute Disease; Adolescent; Adult; Bacterial Infections; Ciprofloxacin; Doxycycline; Drug Evaluation; | 1989 |
13 other studies available for ciprofloxacin and Adnexitis
| Article | Year |
|---|---|
Salmonella: the pelvic masquerader.
Topics: Abscess; Adnexal Diseases; Anti-Bacterial Agents; Ciprofloxacin; Female; Humans; Hysterectomy; Middl | 2009 |
Pelvic inflammatory disease with Tc-99m ciprofloxacin imaging.
Topics: Adult; Ciprofloxacin; Female; Humans; Nucleic Acid Synthesis Inhibitors; Organotechnetium Compounds; | 2008 |
Pelvic abscess following microwave endometrial ablation.
Topics: Abscess; Adult; Anti-Infective Agents; Catheter Ablation; Ciprofloxacin; Endometrium; Female; Humans | 2005 |
Efficacy and safety of ciprofloxacin in gynaecological infections.
Topics: Acute Disease; Administration, Oral; Anti-Infective Agents; Bacterial Infections; Chronic Disease; C | 1989 |
Clinical efficacy and safety of oral ciprofloxacin in pelvic inflammatory disease.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Female; Hum | 1989 |
National guideline for the management of pelvic infection and perihepatitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Cefoxitin; Ceftriaxone; Ciprofloxacin; Clindamycin; Contact Tracing; Female; | 1999 |
Imaging pelvic inflammatory disease with Tc-99m ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Female; Humans; Pelvic Inflammatory Disease; Radionuclide Imag | 2000 |
Ciprofloxacin monotherapy for acute pelvic infections: a comparison with clindamycin plus gentamicin.
Topics: Bacterial Infections; Ciprofloxacin; Clindamycin; Female; Gentamicins; Humans; Pelvic Inflammatory D | 1992 |
The effect of ciprofloxacin and doxycycline plus metronidazole on lower genital tract flora in patients with proven pelvic inflammatory disease.
Topics: Adult; Bacteriological Techniques; Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Doxyc | 1991 |
Intravenous and oral ciprofloxacin in the treatment of proven pelvic inflammatory disease. A comparison with doxycycline and metronidazole.
Topics: Administration, Oral; Bacteria; C-Reactive Protein; Ciprofloxacin; Doxycycline; Drug Therapy, Combin | 1989 |
[Ciprofloxacin management of pelvic inflammation caused by Salmonella panama].
Topics: Abscess; Ciprofloxacin; Female; Humans; Pelvic Inflammatory Disease; Salmonella Infections | 1989 |
Pelvic inflammatory disease caused by Salmonella panama and its treatment with ciprofloxacin. Case report.
Topics: Adult; Ciprofloxacin; Female; Humans; Pelvic Inflammatory Disease; Salmonella Infections | 1989 |
Is pelvic inflammatory disease an indication for treatment with ciprofloxacin?
Topics: Adult; Ciprofloxacin; Escherichia coli Infections; Female; Humans; Pelvic Inflammatory Disease; Pilo | 1988 |